Analysis of VEGF gene polymorphisms and serum VEGF protein levels contribution in polycystic ovary syndrome of patients
Vascular endothelial growth factor (VEGF) is a well-known factor in reproductive function and contributes to the pathogenesis of polycystic ovary syndrome (PCOS). Genetic variations in VEGFA gene were suggested to contribute alterations in VEGF secretion and PCOS. This study evaluated the association of VEGFA SNPs with altered VEGF secretion level and PCOS among ethnically-matched control women. This prospective case–control study was conducted from 2016 to 2018 and comprised of 55 women with PCOS and 52 control subjects. ELISA was used to measure VEGF levels; and various other related bio chemicals whereas the genotyping of VEGFA variants was performed through the analysis of nine SNPs of VEGF. PRL, E2, PRGE testosterone and glucose level were found to be insignificantly different. The levels of FSH, LH, LH/FSH, TT, insulin, SHBG and HOMA-IR were significantly higher in the study group. Among the nine tested variants of VEGF SNPs, two SNPs rs3025020 and rs833061, consisted of TT (Recessive and Dominant homozygous, respectively) which were marginally higher in test. The SNP rs1570360 had significantly higher GG allele (32.73%) which was recessive homozygous. There was no significant difference observed in genotype frequencies related to higher value of VEGF. The genotype frequencies for the studied SNPs were in alignment with Hardy–Weinberg equilibrium (HWE). The mean serum VEGF levels got significantly increased in PCOS group. No significant association was found between VEGF genotypes and its serum levels. VEGF levels in rs699947 (AA-major homozygous), rs3025039 (CC-major homozygous) and rs833061 (TT & CC-major & minor homozygous) genotypes were significantly higher in PCOS. The study results evidently proved that the allelic variants in genes may be a factor for PCOS and VEGF serum levels with respect to few SNP variants only. These findings indicated that VEGF may be involved in PCOS status and confirmed the previous association between genetic variants in VEGF, serum level of VEGF protein and PCOS.
KeywordsVascular endothelial growth factor (VEGF) Polycystic ovary syndrome (PCOS) genetic variation Single nucleotide polymorphism Serum VEGF levels
Compliance with ethical standards
Conflicts of interest
The authors declare that they have no conflict of interest.
Written informed consent was obtained from the participants and in case of the minor study participant, informed consent was granted from the legally authorized representatives of the minors with the option to withdraw them from the study at any time.
- 6.Norman RJ, Dewailly D, Legro RS, Hickey TE (2007) Polycystic ovary syndrome. Lancet 370:685697Google Scholar
- 14.Lee SJ, Lee SY, Jeon HS, Park SH, Jang JS, Lee GY, Son JW, Kim CH, Lee WK, Kam S, Park RW (2005) Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Prev Biomark 14:571–575Google Scholar
- 17.Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow J, Dickler M (2008) Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. J Clin Oncol 26:4672PubMedPubMedCentralGoogle Scholar
- 19.Agrawal R, Sladkevicius P, Engmann L, Conway GS, Payne NN, Bekis J et al (2008) Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod 13:651–655Google Scholar
- 20.Artini PG, Ruggiero M, Parisen Toldin MR, Monteleone P, Monti M, Cela V et al (2009) Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF. Hum Fertil 12:40–44Google Scholar
- 21.El Behery MM, Diab AE, Mowafy H, Ebrahiem MA, Shehata AE (2011) Effect of laparoscopic ovarian drilling on vascular endothelial growth factor and ovarian stromal blood flow using 3-dimensional power Doppler. Int J Gynecol Obstet 112:119–121Google Scholar
- 22.Andraweera PH, Dekker GA, Dissanayke VHW, Bianco-Miotto T, Jayasekara RW, Roberts CT (2013) Vascular endothelial growth factor family gene polymorphisms in preeclampsia in Sinhalese women in Sri Lanka. J Matern Fetal Med 26:532–536Google Scholar
- 27.Li L, Donghong L, Shuguang W, Hongbo Z, Jing Z, Shengbin L (2013) Polymorphisms in the vascular endothelial growth factor gene associated with recurrent spontaneous miscarriage. J Matern Fetal Med 26:686–690Google Scholar
- 29.Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19–25Google Scholar
- 30.Patel SR, Korytkowski MT (2000) Polycystic ovary syndrome: how best to establish a diagnosis. Women Health Prim Care 3:55–69Google Scholar
- 33.Salem AB, Megdich F, Kacem O, Souayeh M, Ali FH, Hizem S, Janhai F, Ajina M, Abu-Elmagd M, Assidi M, Al Qahtani MH (2016) Vascular endothelial growth factor (VEGFA) gene variation in polycystic ovary syndrome in a Tunisian women population. BMC Genom 17(9):748Google Scholar
- 43.Artini PG, Ruggiero M, Parisen Toldin MR, Monteleone P, Monti M, Cela V, Genazzani AR (2009) Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF. Hum Fertil 12(1):40–44Google Scholar
- 45.Nakajima K-I, Nakamura M, Ishisaki A, Kozakai T (2009) Synergistic effect of dexamethasone and prolactin on VEGF expression in bovine mammary epithelial cells via p44/p42 MAP kinase. Asian-Aust J Anim Sci 22(6):788–795Google Scholar